"Blockbuster Weight Loss Drug Maker Warns Against Vanity Use in New Ad Campaign Ahead of Oscars"

Ahead of the Oscars, Eli Lilly, the maker of weight loss drugs Zepbound and Mounjaro, is launching a new ad campaign urging against the "vanity" use of their medications for quick cosmetic weight loss. The company's CEO emphasized that these drugs were developed for people with serious health conditions related to obesity and diabetes, and not for celebrities or others seeking to slim down for aesthetic reasons. The ad campaign aims to prioritize access to the drugs for those who truly need them, as they are already in short supply and face poor insurance coverage. The company is also working to change the perception of obesity and promote empathy for those affected by it.